−39JPY
−7.44 BJPY
152.99 MJPY
203.48 M
About ANGES INC
Sector
Headquarters
Osaka
Employees (FY)
145
Website
Founded
1999
ISIN
JP3127700007
FIGI
BBG000P1KJ14
AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations. The company was founded on December 17, 1999 and is headquartered in Ibaraki, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4563 is 55.00 JPY — it has increased by 7.84% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange ANGES INC stocks are traded under the ticker 4563.
ANGES INC is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track ANGES INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, 4563 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ANGES INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 145.00 employees. See our rating of the largest employees — is ANGES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ANGES INC EBITDA is −8.86 B JPY, and current EBITDA margin is −5.79 K%. See more stats in ANGES INC financial statements.